Total Payments
$8,008
2024 Payments
$1,431
Companies
28
Transactions
238
Medicare Patients
5,064
Medicare Billing
$376,920
Payment Breakdown by Category
Food & Beverage$7,989 (99.8%)
Education$18.47 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,989 | 235 | 99.8% |
| Education | $18.47 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,235 | 93 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $641.08 | 25 | $0 (2020) |
| Genentech USA, Inc. | $573.89 | 6 | $0 (2020) |
| EMD Serono, Inc. | $492.20 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $412.54 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $366.15 | 3 | $0 (2019) |
| Allergan, Inc. | $358.82 | 22 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $339.00 | 9 | $0 (2019) |
| Biogen, Inc. | $330.99 | 5 | $0 (2023) |
| PFIZER INC. | $270.55 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,431 | 44 | ABBVIE INC. ($819.37) |
| 2023 | $833.03 | 21 | PFIZER INC. ($134.29) |
| 2022 | $1,109 | 33 | ABBVIE INC. ($723.47) |
| 2021 | $911.32 | 30 | AbbVie Inc. ($610.86) |
| 2020 | $643.39 | 23 | Allergan, Inc. ($271.83) |
| 2019 | $1,405 | 50 | Novartis Pharmaceuticals Corporation ($366.44) |
| 2018 | $732.03 | 19 | Teva Pharmaceuticals USA, Inc. ($245.22) |
| 2017 | $942.76 | 18 | Genentech USA, Inc. ($154.57) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: PAIN | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Neurology | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Neuropsychiatry | ||||||
| 05/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,216 | 1,411 | $338,695 | $94,009 |
| 2022 | 11 | 1,228 | 1,490 | $348,005 | $94,351 |
| 2021 | 13 | 1,396 | 1,655 | $409,152 | $118,026 |
| 2020 | 10 | 1,224 | 1,439 | $295,402 | $70,535 |
Total Patients
5,064
Total Services
5,995
Medicare Billing
$376,920
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 463 | 583 | $121,264 | $33,066 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 216 | 216 | $69,768 | $24,642 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 235 | $72,145 | $19,912 | 27.6% |
| 92540 | Evaluation and testing for balance with recording | Facility | 2023 | 65 | 65 | $15,145 | $3,738 | 24.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 83 | 121 | $16,577 | $3,712 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $20,636 | $3,638 | 17.6% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 34 | 34 | $10,812 | $2,314 | 21.4% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 27 | 27 | $6,426 | $1,547 | 24.1% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Facility | 2023 | 63 | 63 | $5,922 | $1,440 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 529 | 717 | $149,136 | $42,606 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 189 | 189 | $58,212 | $14,124 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 174 | $53,418 | $13,536 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 95 | 95 | $30,685 | $10,323 | 33.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 78 | 126 | $17,262 | $4,229 | 24.5% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 44 | 44 | $13,992 | $3,477 | 24.8% |
| 92540 | Evaluation and testing for balance with recording | Facility | 2022 | 56 | 56 | $13,048 | $3,185 | 24.4% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Facility | 2022 | 53 | 53 | $4,982 | $1,201 | 24.1% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 11 | 11 | $2,618 | $602.06 | 23.0% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2022 | 13 | 13 | $2,600 | $550.17 | 21.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 12 | 12 | $2,052 | $517.23 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 327 | 430 | $132,026 | $37,780 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 456 | 567 | $117,936 | $34,812 | 29.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 160 | 160 | $51,680 | $18,605 | 36.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 153 | 153 | $47,124 | $12,005 | 25.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 82 | 124 | $16,988 | $4,213 | 24.8% |
About Dr. Randall Stahly, D.O
Dr. Randall Stahly, D.O is a Neurology healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649320532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randall Stahly, D.O has received a total of $8,008 in payments from pharmaceutical and medical device companies, with $1,431 received in 2024. These payments were reported across 238 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($7,989).
As a Medicare-enrolled provider, Stahly has provided services to 5,064 Medicare beneficiaries, totaling 5,995 services with total Medicare billing of $376,920. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cape Girardeau, MO
- Active Since 01/11/2007
- Last Updated 02/26/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1649320532
Products in Payments
- UBRELVY (Drug) $1,779
- QULIPTA (Drug) $621.43
- EPIDIOLEX (Drug) $412.54
- GILENYA (Drug) $379.30
- APTIOM (Drug) $366.15
- MAYZENT (Drug) $250.80
- XCOPRI (Drug) $250.45
- OCREVUS (Biological) $244.36
- AUSTEDO (Drug) $224.05
- TYSABRI (Biological) $201.32
- NURTEC ODT (Drug) $198.13
- Briviact (Drug) $176.75
- INGREZZA (Drug) $165.08
- Activase (Biological) $160.06
- Mavenclad (Biological) $137.05
- ULTOMIRIS (Biological) $134.13
- TECFIDERA (Drug) $129.67
- NUEDEXTA (Drug) $127.71
- Ponvory (Drug) $124.77
- SOLIRIS (Drug) $123.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cape Girardeau
Robert Gardner, Md, MD
Neurology — Payments: $103,392
Neurology $103,392
David Lee, Md, MD
Neurology — Payments: $23,480
Neurology $23,480
James Laguardia, M.d, M.D
Neurology — Payments: $4,860
Neurology $4,860
Dr. Aleksey Androsov, M.d, M.D
Neurology — Payments: $4,536
Neurology $4,536
Dr. Mark Farrenburg, M.d, M.D
Neurology — Payments: $2,221
Neurology $2,221
Richard Ronca
Neurology — Payments: $413.49
Neurology $413.49